Kiniksa Pharmaceuticals, Ltd.·4

Jun 7, 4:41 PM ET

Cole G Bradley 4

4 · Kiniksa Pharmaceuticals, Ltd. · Filed Jun 7, 2024

Insider Transaction Report

Form 4
Period: 2024-06-05
Transactions
  • Exercise/Conversion

    Class A Common Share

    2024-06-06+4,3739,373 total
  • Award

    Share Option

    2024-06-05+19,04019,040 total
    Exercise: $19.71Exp: 2034-06-04Class A Common Shares (19,040 underlying)
  • Award

    Restricted Share Units

    2024-06-05+3,1733,173 total
    Class A Common Shares (3,173 underlying)
  • Exercise/Conversion

    Restricted Share Units

    2024-06-064,3730 total
    Class A Common Shares (4,373 underlying)
Footnotes (4)
  • [F1]Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
  • [F2]The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant. The date of the grant is June 5, 2024.
  • [F3]The RSUs vest in their entirety on the first anniversary date of the grant, June 5, 2024.
  • [F4]The RSUs vested in a single installment on June 6, 2024; there was no expiration date for the RSUs.

Documents

1 file
  • 4
    form4-06072024_080618.xmlPrimary